ED
PNW icon

Exane Derivatives’s Pinnacle West Capital PNW Stock Holding History

Exane Derivatives’s Portfolio PNW Stock Details PNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-347,415
Closed -$22.1M – 548
2015
Q1 		$22.1M Buy
347,415
+151,698
+78% +$10.1M 2.44% 10
2014
Q4 		$13.4M Buy
+195,717
New +$12.2M 1.85% 10

Other funds holding PNW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Exane Derivatives's PNW Position: Q2 2015 in Review

Exane Derivatives sold out of Pinnacle West Capital (PNW) in Q2 2015, closing a stake of 347,415 shares — an estimated $22.1M sold.

Exane Derivatives first reported a position in PNW in Q4 2014 and held it in 2 quarters. The position peaked at $22.1M in Q1 2015. 401 funds tracked by Wall St. Rank hold PNW as of Q2 2015.

  • Exane Derivatives reported no remaining Pinnacle West Capital position as of Q2 2015 after selling out during the quarter.
  • Exane Derivatives sold 347,415 Pinnacle West Capital shares in Q2 2015, an estimated $22.1M.
  • Exane Derivatives first reported a position in Pinnacle West Capital in Q4 2014 and held it in 2 quarters.
  • Exane Derivatives's Pinnacle West Capital position peaked at $22.1M in Q1 2015.
  • 401 funds tracked by Wall St. Rank held Pinnacle West Capital as of Q2 2015.

Based on Exane Derivatives's 13F filing for Q2 2015, filed 14 Aug 2015.